Hemo Organic Limited (BSE: 524590) is an Ahmedabad, Gujarat-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹0 Cr, it ranks #5,450 by market cap among the 6,197 Indian listed companies on FinBizNet, and #84 of 86 in Medicinal Chemicals and Botanical Products. At ₹20.99 (as of 16 Nov 2026), the share price is 14.0% below its 52-week high of ₹24.42 and 116.2% above its 52-week low of ₹9.71. The share price is up 149.9% over one year and up 0.2% over three months.
| Current Price | ₹20.99 |
|---|---|
| Market Cap | ₹0 Cr |
| BSE Code | 524590 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products |
| P/E Ratio | Not meaningful (loss) |
| Return on Equity | 83.67% |
| Return on Assets | -6.60% |
| 52-Week Range | ₹9.71 – ₹24.42 |
| 1-Year Price Change | +149.9% |
| 3-Month Price Change | +0.2% |
| Beta (1Y) | -0 |
| Headquarters | Ahmedabad, Gujarat |
| Website | www.hemoorganic.co |
Hemo Organic Limited engages in the buying, selling, reselling, importing, exporting, transporting, storing, developing, promoting, supplying, marketing, and dealing of the agricultural products in India and internationally. It trades in wheat, rice, and maize; vegetables, including capsicum, tomato, green chili, potato, cucumber, and onion; and fruits, such as apple, red dragon fruit, sweet lime, and pomegranate. The company was formerly known as Dinesh Allorga Limited and changed its name to Hemo Organic Limited in August 2013. The company was incorporated in 1992 and is based in Ahmedabad, India.
1. Manufacturing of Bio Coal-This segment manufactures ayurvedic or unani pharmaceutical preparations. 2. Pharmaceuticals-This segment engages in the production and sale of white coal.
1. Trading and Distribution-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4,56,425 Cr | 39.5 | 14.72% | ₹16,199 Cr | +11.2% |
| Laurus Labs Ltd | ₹1,31,242 Cr | 145.6 | 17.74% | ₹2,206 Cr | +146.8% |
| Zydus Lifesciences Ltd | ₹1,19,651 Cr | 24.1 | 18.32% | ₹7,910 Cr | +26.0% |
| Dr.Reddys Lab | ₹1,15,464 Cr | 26.9 | 11.52% | ₹8,698 Cr | +14.5% |
| Cipla Limited | ₹1,14,712 Cr | 29.3 | 11.74% | ₹7,404 Cr | -7.6% |
| Mankind Pharma | ₹1,09,870 Cr | 57 | 12.45% | ₹4,338 Cr | +16.7% |
| Aurobindo Pharma Ltd. | ₹1,05,150 Cr | 30 | 9.93% | ₹10,263 Cr | +59.8% |
| Lupin Ltd | ₹92,087 Cr | 17.3 | 26.91% | ₹7,827 Cr | +0.4% |
| Hemo Organic Limited | ₹0 Cr | n/m | 83.67% | — | +149.9% |
Listed by market capitalisation. Ratios are shown for context only.
Hemo Organic Limited is trading at ₹20.99, with a market capitalisation of ₹0 Cr.
Hemo Organic Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).
Hemo Organic Limited has a return on equity of 83.67%.
Hemo Organic Limited is listed on the BSE under the scrip code 524590.
Hemo Organic Limited's share price is up 149.9% over one year and up 0.2% over three months. Its 52-week range is ₹9.71 to ₹24.42.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.